HomeCompareAMEUF vs DVY

AMEUF vs DVY: Dividend Comparison 2026

AMEUF yields 35.09% · DVY yields 3.46%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AMEUF wins by $151.7K in total portfolio value
10 years
AMEUF
AMEUF
● Live price
35.09%
Share price
$5.70
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$176.8K
Annual income
$26,756.35
Full AMEUF calculator →
DVY
DVY
● Live price
3.46%
Share price
$151.41
Annual div
$5.25
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.0K
Annual income
$432.91
Full DVY calculator →

Portfolio growth — AMEUF vs DVY

📍 AMEUF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMEUFDVY
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMEUF + DVY cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AMEUF pays
DVY pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMEUF
Annual income on $10K today (after 15% tax)
$2,982.46/yr
After 10yr DRIP, annual income (after tax)
$22,742.90/yr
DVY
Annual income on $10K today (after 15% tax)
$294.47/yr
After 10yr DRIP, annual income (after tax)
$367.97/yr
At 15% tax rate, AMEUF beats the other by $22,374.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMEUF + DVY for your $10,000?

AMEUF: 50%DVY: 50%
100% DVY50/50100% AMEUF
Portfolio after 10yr
$100.9K
Annual income
$13,594.63/yr
Blended yield
13.47%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMEUF buys
0
DVY buys
0
No recent congressional trades found for AMEUF or DVY in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMEUFDVY
Forward yield35.09%3.46%
Annual dividend / share$2.00$5.25
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$176.8K$25.0K
Annual income after 10y$26,756.35$432.91
Total dividends collected$127.6K$3.9K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: AMEUF vs DVY ($10,000, DRIP)

YearAMEUF PortfolioAMEUF Income/yrDVY PortfolioDVY Income/yrGap
1← crossover$14,209$3,508.77$11,046$346.43+$3.2KAMEUF
2$19,863$4,659.38$12,177$357.65+$7.7KAMEUF
3$27,340$6,087.34$13,398$368.47+$13.9KAMEUF
4$37,085$7,830.87$14,715$378.89+$22.4KAMEUF
5$49,608$9,927.06$16,134$388.90+$33.5KAMEUF
6$65,491$12,410.52$17,662$398.51+$47.8KAMEUF
7$85,388$15,312.15$19,306$407.71+$66.1KAMEUF
8$110,023$18,657.99$21,074$416.50+$88.9KAMEUF
9$140,193$22,468.21$22,974$424.90+$117.2KAMEUF
10$176,763$26,756.35$25,015$432.91+$151.7KAMEUF

AMEUF vs DVY: Complete Analysis 2026

AMEUFStock

Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.

Full AMEUF Calculator →

DVYETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →
📬

Get this AMEUF vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMEUF vs SCHDAMEUF vs JEPIAMEUF vs OAMEUF vs KOAMEUF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.